Results 151 to 160 of about 47,734 (283)

In-vitro activities of amphotericin B, itraconazole and voriconazole against 150 clinical and environmental Aspergillus fumigatus isolates.

open access: bronze, 1998
Paul E. Verweij   +5 more
openalex   +1 more source

The effect of itraconazole and rifampicin on the pharmacokinetics of osimertinib

open access: yesBritish Journal of Clinical Pharmacology, 2018
K. Vishwanathan   +13 more
semanticscholar   +1 more source

Pharmacokinetics and Pharmacodynamics of Fosravuconazole, Itraconazole, and Hydroxyitraconazole in Sudanese Patients With Eumycetoma. [PDF]

open access: yesJ Infect Dis
Chu WY   +21 more
europepmc   +1 more source

Impact of Drug-Rich Colloids of Itraconazole and HPMCAS on Membrane Flux in Vitro and Oral Bioavailability in Rats.

open access: yesMolecular Pharmaceutics, 2017
Aaron M. Stewart   +6 more
semanticscholar   +1 more source

Sporothrix brasiliensis Treatment Failure without Initial Elevated Itraconazole MICs in Felids at Border of Brazil. [PDF]

open access: yesEmerg Infect Dis
do Prado CM   +14 more
europepmc   +1 more source

Biological properties of itraconazole-SLN

open access: yes, 2018
Itraconazole (ITZ) belongs to azoles, an important family of antifungal drugs, and has been used for more than 30 years in clinical applications. These drugs inhibit lanosterol 1-4demethylase, the enzyme that converts lanosterol to ergosterol. As recently demonstrated, topical formulations of ITZ in solid lipid nanoparticles (SLN) and a coating layer ...
V. Fuochi   +9 more
openaire   +4 more sources

Home - About - Disclaimer - Privacy